APO-ACEBUTOLOL 100 MG
ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE) : 100 MG · DIN 02147602 · APOTEX INC
Health Canada status: MARKETED
What is APO-ACEBUTOLOL?
APO-ACEBUTOLOL 100 MG contains ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE) : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02147602, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Dec-1995. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02147602 |
|---|---|
| Brand name | APO-ACEBUTOLOL |
| Generic / active ingredient | ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE) : 100 MG |
| Manufacturer | APOTEX INC |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C07AB04 ACEBUTOLOL |
| AHFS class | 24:24.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Dec-1995 |
| Original market date | 1995-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C07AB04 ACEBUTOLOL. 6 of 44 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-ACEBUTOLOL | 200 MG | TABLET | APOTEX INC | MARKETED | DIN 02147610 |
| APO-ACEBUTOLOL | 400 MG | TABLET | APOTEX INC | MARKETED | DIN 02147629 |
| TEVA-ACEBUTOLOL | 100 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02204517 |
| TEVA-ACEBUTOLOL | 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02204525 |
| TEVA-ACEBUTOLOL | 400 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02204533 |
| ACEBUTOLOL | 100 MG | TABLET | SANIS HEALTH INC | CANCELLED POST MARKET | DIN 02286246 |
| ACEBUTOLOL | 200 MG | TABLET | SANIS HEALTH INC | CANCELLED POST MARKET | DIN 02286254 |
| ACEBUTOLOL | 400 MG | TABLET | SANIS HEALTH INC | CANCELLED POST MARKET | DIN 02286262 |
| ACEBUTOLOL - 400 | 400 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02164426 |
| ACEBUTOLOL-100 | 100 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02164396 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.